Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CERUS CORPCERS · Entity 5431 | Chief Scientific Officer | March 12, 2024 | March 15, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CERUS CORP
Report date March 12, 2024 · Filed March 15, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,339,740 |
Ending reported balance
After 2024-03-14 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2024-03-12 · Exercise / conversion · Acquired 16,666 · Balance 2,368,167 F1: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Row 2 · 2024-03-13 · Sale · Disposed 14,067 · Balance 2,354,100 F2: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F3: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.025 to $2.10 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Row 3 · 2024-03-14 · Sale · Disposed 14,360 · Balance 2,339,740 F2: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F4: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.935 to $2.04 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-03-12 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-03-12 · Exercise / conversion · Disposed 16,666 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6: Not applicable. F5: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.
F2: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person.
F3: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.025 to $2.10 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
F4: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.935 to $2.04 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
F5: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022.
F6: Not applicable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 14, 2024 Filed Mar 15, 2024 01:22 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 14,360 | $1.97 | $28,352.38 |
DisclosureSEC source: 0001209191-24-004847 · doc4.xml · nonDerivative · entry 3 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,339,740 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.935 to $2.04 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 01:22 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 14,067 | $2.06 | $28,935.82 |
DisclosureSEC source: 0001209191-24-004847 · doc4.xml · nonDerivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,354,100 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.025 to $2.10 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 12, 2024 Filed Mar 15, 2024 01:22 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 16,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-004847 · doc4.xml · derivative · entry 4 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
| March 12, 2024 Filed Mar 15, 2024 01:22 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 16,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-004847 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,368,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:16 UTC | CERUS CORP CERS · Entity 5431 | GrantRestricted Stock Unit | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-004441 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,351,501 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 1/3 of the grant vesting on March 12, 2025, and 2/3 of the grant vesting on March 12, 2026, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 23:38 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 5,745 | $2.80 | $16,086.00 |
DisclosureSEC source: 0001209191-23-018680 · doc4.xml · nonDerivative · entry 4 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,261,501 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 23:38 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 9,597 | $2.80 | $26,871.60 |
DisclosureSEC source: 0001209191-23-018680 · doc4.xml · nonDerivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,250,579 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:38 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 16,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018680 · doc4.xml · derivative · entry 6 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,666 Underlying: Common Stock · 16,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:38 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 23,460 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018680 · doc4.xml · derivative · entry 5 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,460 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. F4 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:38 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 16,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018680 · doc4.xml · nonDerivative · entry 3 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,267,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 23:38 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 23,460 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-018680 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,260,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:14 UTC | CERUS CORP CERS · Entity 5431 | GrantRestricted Stock Unit | 110,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-015748 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,236,716 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2024, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 01:57 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 5,982 | $5.04 | $30,146.89 |
DisclosureSEC source: 0001209191-22-019064 · doc4.xml · nonDerivative · entry 6 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,126,716 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 01:57 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 8,173 | $5.04 | $41,188.65 |
DisclosureSEC source: 0001209191-22-019064 · doc4.xml · nonDerivative · entry 4 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,116,031 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 01:57 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 16,152 | $5.04 | $81,399.62 |
DisclosureSEC source: 0001209191-22-019064 · doc4.xml · nonDerivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,101,434 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.871 to $5.22 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:57 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 16,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019064 · doc4.xml · derivative · entry 9 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,333 Underlying: Common Stock · 16,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F7 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F7 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:57 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 22,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019064 · doc4.xml · derivative · entry 8 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,460 Underlying: Common Stock · 22,770 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. F6 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2021, 33% on March 12, 2022 and 34% on March 12, 2023. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:57 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019064 · doc4.xml · derivative · entry 7 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests 33% on March 12, 2020, 33% on March 12, 2021 and 34% on March 12, 2022. F4 · derivative.expiration_date: The restricted stock unit vests 33% on March 12, 2020, 33% on March 12, 2021 and 34% on March 12, 2022. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:57 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 16,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019064 · doc4.xml · nonDerivative · entry 5 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,132,698 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:57 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 22,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019064 · doc4.xml · nonDerivative · entry 3 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,124,204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2022 Filed Mar 16, 2022 01:57 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-019064 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,117,586 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:40 UTC | CERUS CORP CERS · Entity 5431 | GrantOption (Right to Buy) · Derivative | 90,000 | Not disclosed Strike: $5.76 | Not disclosed |
DisclosureSEC source: 0001209191-22-015921 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2032-02-28 F3 · price: Not applicable. F2 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the Option shall vest on the first anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:40 UTC | CERUS CORP CERS · Entity 5431 | GrantRestricted Stock Unit | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015921 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,072,586 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2023, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 22:29 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionOption (Right to Buy) · Derivative | 5,000 | Not disclosed Strike: $3.75 | Not disclosed |
DisclosureSEC source: 0001209191-21-070809 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter. Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 22:29 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 5,000 | $3.75 | $18,750.00 |
DisclosureSEC source: 0001209191-21-070809 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,027,586 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2021 Filed Dec 16, 2021 01:57 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionOption (Right to Buy) · Derivative | 40,000 | Not disclosed Strike: $3.75 | Not disclosed |
DisclosureSEC source: 0001209191-21-069864 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 40,000 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter. Read SEC document |
| December 13, 2021 Filed Dec 16, 2021 01:57 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 40,000 | $3.75 | $150,000.00 |
DisclosureSEC source: 0001209191-21-069864 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,022,586 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2021 Filed May 5, 2021 01:12 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionOption (Right to Buy) · Derivative | 25,200 | Not disclosed Strike: $3.66 | Not disclosed |
DisclosureSEC source: 0001209191-21-030178 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,200 shares Expires 2023-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter. Read SEC document |
| April 30, 2021 Filed May 5, 2021 01:12 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 25,200 | $3.66 | $92,232.00 |
DisclosureSEC source: 0001209191-21-030178 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,982,586 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:34 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 7,989 | $6.38 | $50,951.45 |
DisclosureSEC source: 0001209191-21-021134 · doc4.xml · nonDerivative · entry 5 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,957,386 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 23:34 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 15,786 | $6.38 | $100,678.37 |
DisclosureSEC source: 0001209191-21-021134 · doc4.xml · nonDerivative · entry 3 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,942,605 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.285 to $6.445 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:34 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 22,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021134 · doc4.xml · derivative · entry 8 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,230 Underlying: Common Stock · 22,770 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F7 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. F7 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:34 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021134 · doc4.xml · derivative · entry 7 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:34 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 15,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021134 · doc4.xml · derivative · entry 6 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:34 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 22,770 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021134 · doc4.xml · nonDerivative · entry 4 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,965,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:34 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021134 · doc4.xml · nonDerivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,958,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 23:34 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 15,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021134 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,913,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:02 UTC | CERUS CORP CERS · Entity 5431 | GrantRestricted Stock Unit · Derivative | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-017443 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 01:02 UTC | CERUS CORP CERS · Entity 5431 | GrantOption (Right to Buy) · Derivative | 100,000 | Not disclosed Strike: $6.52 | Not disclosed |
DisclosureSEC source: 0001209191-21-017443 · doc4.xml · derivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-02-28 F2 · price: Not applicable. F1 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the Option shall vest on the first anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 00:47 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionOption (Right to Buy) · Derivative | 94,800 | Not disclosed Strike: $3.66 | Not disclosed |
DisclosureSEC source: 0001209191-20-025501 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,200 Underlying: Common Stock · 94,800 shares Expires 2023-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 00:47 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 94,800 | $3.66 | $346,968.00 |
DisclosureSEC source: 0001209191-20-025501 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,897,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 17, 2020 Filed Mar 25, 2020 01:12 UTC | CERUS CORP CERS · Entity 5431 | SaleCommon Stock | 17,500 | $3.59 | $62,907.25 |
DisclosureSEC source: 0001209191-20-021045 · doc4.xml · nonDerivative · entry 4 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,802,758 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II and does not represent a discretionary sale by the reporting person. Read SEC document |
| March 17, 2020 Filed Mar 25, 2020 01:12 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021045 · doc4.xml · nonDerivative · entry 3 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,820,258 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 17, 2020 Filed Mar 25, 2020 01:12 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 15,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021045 · doc4.xml · nonDerivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,775,258 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 17, 2020 Filed Mar 25, 2020 01:12 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021045 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,759,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2020 Filed Mar 25, 2020 01:12 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021045 · doc4.xml · derivative · entry 7 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 45,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F4 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. Read SEC document |
| March 12, 2020 Filed Mar 25, 2020 01:12 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 15,833 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021045 · doc4.xml · derivative · entry 6 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,833 Underlying: Common Stock · 15,833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F4 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. Read SEC document |
| March 12, 2020 Filed Mar 25, 2020 01:12 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-021045 · doc4.xml · derivative · entry 5 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F4 · price: Not applicable. F3 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. F3 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. Read SEC document |
| March 02, 2020 Filed Mar 16, 2021 23:03 UTC | CERUS CORP CERS · Entity 5431 | GrantRestricted Stock Unit · Derivative | 69,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-021103 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,000 Underlying: Common Stock · 69,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2021. Read SEC document |
| March 02, 2020 Filed Mar 16, 2021 23:03 UTC | CERUS CORP CERS · Entity 5431 | GrantOption (Right to Buy) · Derivative | 138,000 | Not disclosed Strike: $5.11 | Not disclosed |
DisclosureSEC source: 0001209191-21-021103 · doc4.xml · derivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,000 Underlying: Common Stock · 138,000 shares Expires 2030-03-01 F2 · price: Not applicable. F1 · derivative.exercise_date: One fourth (1/4th) of the shares subject to the Option shall vest on the first anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.